Home » Topics » BioWorld Science

BioWorld Science
RSS

Eli Lilly and Company synthesizes GTPase KRAS mutant inhibitors

July 7, 2021

Kymera Therapeutics patents new PROTACs

July 7, 2021

Shionogi discloses new HDAC2 inhibitors

July 7, 2021

Vanderbilt University patents muscarinic M4 receptor antagonists

July 7, 2021

FDA clears IND for AGEN-1777

July 7, 2021

Positive phase I data for UBX-1325 in patients with advanced vascular eye disease

July 7, 2021

First patient dosed in phase IIb study of Lomecel-B in hypoplastic left heart syndrome

July 7, 2021

Positive interim data from phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma

July 7, 2021

New beta-amyloid PET imaging agent [18F]Flotaza shows promise in Alzheimer's disease brain

July 7, 2021

TruLarv standardized Galleria mellonella developed for screening new antimicrobials

July 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...